Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
Sensus Healthcare (Nasdaq: SRTS), a medical device company focused on non-invasive treatments, announces its upcoming Third Quarter 2024 financial results conference call scheduled for November 14, 2024, at 4:30 p.m. Eastern time. Management will discuss Q3 2024 financial results, provide business updates, and review recent and upcoming milestones. The call will be accessible via pre-registration or direct dial-in, with a replay available until December 14, 2024. A webcast will also be available through the company's website.
Sensus Healthcare (Nasdaq: SRTS), un'azienda di dispositivi medici specializzata in trattamenti non invasivi, annuncia la conference call per i risultati finanziari del terzo trimestre 2024 programmata per il 14 novembre 2024, alle 16:30 ora orientale. La direzione discuterà i risultati finanziari del Q3 2024, fornirà aggiornamenti sull'attività e esaminerà traguardi recenti e futuri. La call sarà accessibile tramite registrazione preliminare o chiamata diretta, con una registrazione disponibile fino al 14 dicembre 2024. Sarà disponibile anche una webcast attraverso il sito web dell'azienda.
Sensus Healthcare (Nasdaq: SRTS), una empresa de dispositivos médicos enfocada en tratamientos no invasivos, anuncia su próxima conferencia telefónica sobre los resultados financieros del tercer trimestre de 2024 programada para el 14 de noviembre de 2024, a las 4:30 p.m. hora del Este. La dirección discutirá los resultados financieros del Q3 2024, proporcionará actualizaciones sobre el negocio y revisará los hitos recientes y futuros. La llamada será accesible a través de preinscripción o marcación directa, con una repetición disponible hasta el 14 de diciembre de 2024. También se ofrecerá una transmisión en vivo a través del sitio web de la empresa.
Sensus Healthcare (Nasdaq: SRTS), 비침습 치료에 집중하는 의료 기기 회사, 2024년 3분기 재무 결과에 대한 컨퍼런스 콜을 2024년 11월 14일 동부 표준시 기준 오후 4시 30분에 예정하고 있음을 발표했습니다. 경영진은 2024년 3분기 재무 결과를 논의하고, 비즈니스 업데이트를 제공하며, 최근 및 향후 이정표를 검토할 것입니다. 이 통화는 사전 등록 또는 직접 전화로 참석할 수 있으며, 2024년 12월 14일까지 재생 가능하다. 회사 웹사이트를 통해 웹캐스트도 이용 가능합니다.
Sensus Healthcare (Nasdaq: SRTS), une entreprise de dispositifs médicaux axée sur des traitements non invasifs, annonce sa prochaine conférence téléphonique sur les résultats financiers du troisième trimestre 2024 prévue pour le 14 novembre 2024 à 16h30, heure de l'Est. La direction discutera des résultats financiers du T3 2024, fournira des mises à jour commerciales et examinera les jalons récents et à venir. L'appel sera accessible par préinscription ou par appel direct, avec un replay disponible jusqu'au 14 décembre 2024. Une webdiffusion sera également disponible via le site web de l'entreprise.
Sensus Healthcare (Nasdaq: SRTS), ein Medizintechnikunternehmen, das sich auf nicht-invasive Behandlungen konzentriert, gibt seine bevorstehende Telefonkonferenz zu den finanziellen Ergebnissen des dritten Quartals 2024 bekannt, die für den 14. November 2024 um 16:30 Uhr Eastern Time geplant ist. Das Management wird die finanziellen Ergebnisse des Q3 2024 erläutern, aktuelle Unternehmensupdates bereitstellen und kürzliche sowie zukünftige Meilensteine überprüfen. Der Anruf ist über eine Voranmeldung oder direkte Einwahl zugänglich, mit einer Wiederholung bis zum 14. Dezember 2024 verfügbar. Außerdem wird eine Webcast über die Unternehmenswebsite bereitgestellt.
- None.
- None.
BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 14, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial-in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register can access the conference call by dialing 844-481-2811 (U.S. and Canada Toll Free) or 412-317-0676 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
The call will be webcast live and can be accessed at this link, which also can be found in the Investor Relations section of the Company’s website at www.sensushealthcare.com.
Following the conclusion of the conference call, a telephone replay will be available until December 14, 2024 and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free) or 412-317-0088 (International). At the system prompt, enter the replay code 3932512 followed by the # sign. An archived webcast of the call will also be available in the Investor Relations section of the Company’s website for a period of time.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.
Contact:
Alliance Advisors IR
Kim Sutton Golodetz
212-838-3777
kgolodetz@allianceadvisors.com
# # #
FAQ
When will Sensus Healthcare (SRTS) report Q3 2024 earnings?
How can investors join Sensus Healthcare's (SRTS) Q3 2024 earnings call?
How long will Sensus Healthcare's (SRTS) Q3 2024 earnings call replay be available?
